67 KD LAMININ BINDING PROTEIN ON HUMAN T LYMPHOCYTES
人类 T 淋巴细胞上的 67 KD 层粘连蛋白结合蛋白
基本信息
- 批准号:6171492
- 负责人:
- 金额:$ 12.34万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1999
- 资助国家:美国
- 起止时间:1999-09-15 至 2004-06-30
- 项目状态:已结题
- 来源:
- 关键词:CD antigens T cell receptor T lymphocyte binding proteins cell migration chemokine clone cells crosslink density gradient ultracentrifugation flow cytometry gene expression human subject immunoprecipitation laminin leukocyte activation /transformation leukocyte adhesion molecules monoclonal antibody polymerase chain reaction protein structure function tissue /cell culture western blottings
项目摘要
T cell interactions with laminin, the major glycoprotein of basement membranes, are important to the inflammatory response. However, the interactions of lymphocyte surface receptors with laminin are only beginning to be understood. A search for genes expressed in activated T cells revealed that the non-integrin, 67 kD laminin binding protein (p67 LBP) is expressed on the surface of a subset (10-15 percent) of activated peripheral blood T cells. Surface p67 LBP expression is detectable by FACS using the anti-p67 LBP mAb, MLuC5, within 6 h of T cell activation with PDB and ionomycin, peaks 24 h post-activation, and persists for 7-10 days. The subset of T cells expressing p67 LBP are mature, single-positive cells (85 percent CD4+/8-, 15 percent CD4-/8+) of memory cell phenotype (100 percent CD45 RO+/CD45 RA-). The p67 LBP+ T cells also express the integrin alpha6 chain (CD49f), which is known to associate with p67 LBP on tumor cells. In addition, the p67 LBP+ T cells express the integrin beta1, which associates with alpha6 in the laminin-specific integrin receptor VLA-6 (alpha6beta1). Expression of an exogenous cDNA encoding the 37 kD LBP precursor (p37 LBPP) confers p67 LBP surface expression on a p67 LBP-negative Jurkat T cell line (B2.7). Expression of p67 LBP induces B2.7 transfectants to adhere to laminin, but avid laminin binding depends on co-expression of high level VLA-6. Taken together, these data indicate that p67 LBP is an activation-induced surface structure on memory T cells that, together with VLA-6, mediates cellular adherence to laminin. We propose to study p67 LBP on normal human T cells and on the Jurkat T cell line in order to address the following specific aims: (1) What stimuli induce the expression of p67 LBP on normal T cells? (2) What is the structure of p67 LBP? (3) What are the contributions of p67 LBP and the integrin alpha6 to lymphocyte laminin-specific adherence? and (4) What are the contributions of p67 LBP and alpha6 to laminin-mediated lamellipod formation, locomotion, and transendothelial migration?
T细胞与基底膜的主要糖蛋白层粘连蛋白的相互作用对炎症反应很重要。然而,淋巴细胞表面受体与层粘连蛋白的相互作用才刚刚开始被理解。 对活化T细胞中表达的基因的搜索显示,非整合素,67 kD层粘连蛋白结合蛋白(p67 LBP)在活化外周血T细胞的亚群(10- 15%)的表面上表达。 表面p67 LBP表达可通过FACS使用抗p67 LBP mAb MLuC 5在用PDB和离子霉素活化T细胞的6小时内检测到,在活化后24小时达到峰值,并持续7-10天。 表达p67 LBP的T细胞亚群是记忆细胞表型(100%CD45 RO+/CD 45 RA-)的成熟的单阳性细胞(85%CD4 +/8-,15%CD4-/8+)。 p67 LBP+ T细胞还表达整合素α 6链(CD 49 f),已知其与肿瘤细胞上的p67 LBP相关。 此外,p67 LBP+ T细胞表达整合素β 1,其与层粘连蛋白特异性整合素受体VLA-6(α 6 β 1)中的α 6相关。 编码37 kD LBP前体(p37 LBPP)的外源cDNA的表达赋予p67 LBP在p67 LBP阴性Jurkat T细胞系(B2.7)上的表面表达。p67 LBP的表达诱导B2.7转染子粘附于层粘连蛋白,但亲合的层粘连蛋白结合依赖于高水平VLA-6的共表达。 总之,这些数据表明,p67 LBP是记忆T细胞上的活化诱导的表面结构,其与VLA-6一起介导细胞粘附层粘连蛋白。 我们拟研究p67 LBP在正常人T细胞和Jurkat T细胞系上的表达,以解决以下具体目标:(1)什么样的刺激诱导p67 LBP在正常T细胞上的表达?(2)p67 LBP的结构是什么?(3)p67 LBP和整合素α 6对淋巴细胞层粘连蛋白特异性粘附的作用是什么?以及(4)p67 LBP和α 6对层粘连蛋白介导的板足形成、运动和跨内皮迁移的贡献是什么?
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Stephen M Canfield其他文献
Stephen M Canfield的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Stephen M Canfield', 18)}}的其他基金
67 KD LAMININ BINDING PROTEIN ON HUMAN T LYMPHOCYTES
人类 T 淋巴细胞上的 67 KD 层粘连蛋白结合蛋白
- 批准号:
6512011 - 财政年份:1999
- 资助金额:
$ 12.34万 - 项目类别:
67KD NON INTEGRIN LAMININ BINDING PROTEIN IN T LYMPHOCYTE MEDIATED SKIN DISEASE
T 淋巴细胞介导的皮肤病中的 67KD 非整合素层粘连蛋白结合蛋白
- 批准号:
6100661 - 财政年份:1999
- 资助金额:
$ 12.34万 - 项目类别:
67 KD LAMININ BINDING PROTEIN ON HUMAN T LYMPHOCYTES
人类 T 淋巴细胞上的 67 KD 层粘连蛋白结合蛋白
- 批准号:
6659036 - 财政年份:1999
- 资助金额:
$ 12.34万 - 项目类别:
STRUCTURE/FUNCTION OF 67 KD LAMININ BINDING PROTEIN ON H
H 上 67 KD 层粘连蛋白结合蛋白的结构/功能
- 批准号:
2908457 - 财政年份:1999
- 资助金额:
$ 12.34万 - 项目类别:
67 KD LAMININ BINDING PROTEIN ON HUMAN T LYMPHOCYTES
人类 T 淋巴细胞上的 67 KD 层粘连蛋白结合蛋白
- 批准号:
6374754 - 财政年份:1999
- 资助金额:
$ 12.34万 - 项目类别:
相似海外基金
The molecular basis of T cell receptor cross-reactivity between MHC and MR1
MHC 和 MR1 之间 T 细胞受体交叉反应的分子基础
- 批准号:
DP240102905 - 财政年份:2024
- 资助金额:
$ 12.34万 - 项目类别:
Discovery Projects
Machine Learning of Disease Biomarkers from B and T cell Receptor Repertoires
来自 B 和 T 细胞受体库的疾病生物标志物的机器学习
- 批准号:
23K28188 - 财政年份:2024
- 资助金额:
$ 12.34万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
CAREER: Understanding the Impact of Dephosphorylation Kinetics and Adapter Specificity on Synthetic T Cell Receptor Signaling and Function
职业:了解去磷酸化动力学和接头特异性对合成 T 细胞受体信号传导和功能的影响
- 批准号:
2339172 - 财政年份:2024
- 资助金额:
$ 12.34万 - 项目类别:
Continuing Grant
Special Public T Cell Receptor Sequences that Predict Outcomes for Cancer Patients
预测癌症患者预后的特殊公共 T 细胞受体序列
- 批准号:
10577518 - 财政年份:2023
- 资助金额:
$ 12.34万 - 项目类别:
Machine Learning of Disease Biomarkers from B and T cell Receptor Repertoires
来自 B 和 T 细胞受体库的疾病生物标志物的机器学习
- 批准号:
23H03498 - 财政年份:2023
- 资助金额:
$ 12.34万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Impact of T cell receptor signaling on memory CD8+ T cell stemness
T 细胞受体信号传导对记忆 CD8 T 细胞干性的影响
- 批准号:
10676407 - 财政年份:2023
- 资助金额:
$ 12.34万 - 项目类别:
T cell receptor cross-reactivity and structural basis of virus immune escape
T细胞受体交叉反应性和病毒免疫逃逸的结构基础
- 批准号:
22KK0277 - 财政年份:2023
- 资助金额:
$ 12.34万 - 项目类别:
Fund for the Promotion of Joint International Research (Fostering Joint International Research (A))
T-cell receptor mimic affinity reagent generation using an in vivo novel immunogen strategy
使用体内新型免疫原策略生成 T 细胞受体模拟亲和试剂
- 批准号:
10599584 - 财政年份:2023
- 资助金额:
$ 12.34万 - 项目类别:
Mechanical regulation of T cell receptor and co-receptor responses in cancer immunotherapy
癌症免疫治疗中 T 细胞受体和辅助受体反应的机械调节
- 批准号:
10530023 - 财政年份:2022
- 资助金额:
$ 12.34万 - 项目类别:
Inhibition of T-cell Receptor Signaling for Treatment of Adult T-cell Leukemia Lymphoma
抑制 T 细胞受体信号转导治疗成人 T 细胞白血病淋巴瘤
- 批准号:
10684172 - 财政年份:2022
- 资助金额:
$ 12.34万 - 项目类别: